Rxsight IncNASDAQ:RXST
- LAST PRICE58.5150
- TODAY'S CHANGE (%)0.0450 (0.0770%)
- Bid / Lots58.4000/ 2
- Ask / Lots58.5900/ 4
- Open / Previous Close58.7200 / 58.4700
- Day Range
- 52 Week Range
- Volume50,114
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RXST |
|---|---|---|
| 09:32 ET | 3274 | 58.47 |
| 09:34 ET | 273 | 58.76 |
| 09:36 ET | 100 | 59.015 |
| 09:38 ET | 1275 | 58.52 |
| 09:39 ET | 100 | 58.99 |
| 09:41 ET | 1061 | 59.1 |
| 09:43 ET | 360 | 59.2162 |
| 09:45 ET | 344 | 59.24 |
| 09:50 ET | 411 | 58.96 |
| 09:54 ET | 137 | 59.1306 |
| 09:56 ET | 100 | 58.925 |
| 09:57 ET | 300 | 58.65 |
| 09:59 ET | 853 | 58.57 |
| 10:01 ET | 100 | 58.86 |
| 10:03 ET | 100 | 58.875 |
| 10:06 ET | 458 | 58.76 |
| 10:08 ET | 930 | 58.83 |
| 10:10 ET | 497 | 58.97 |
| 10:12 ET | 210 | 59 |
| 10:14 ET | 1626 | 59.085 |
| 10:15 ET | 1183 | 59.14 |
| 10:17 ET | 200 | 58.91 |
| 10:19 ET | 400 | 58.93 |
| 10:21 ET | 285 | 58.885 |
| 10:24 ET | 100 | 58.73 |
| 10:26 ET | 200 | 58.9965 |
| 10:28 ET | 100 | 58.78 |
| 10:30 ET | 100 | 58.895 |
| 10:32 ET | 687 | 58.957 |
| 10:33 ET | 3300 | 58.76 |
| 10:35 ET | 600 | 58.68 |
| 10:37 ET | 100 | 58.61 |
| 10:39 ET | 100 | 58.6 |
| 10:42 ET | 400 | 58.68 |
| 10:44 ET | 400 | 58.755 |
| 10:46 ET | 353 | 58.755 |
| 10:48 ET | 245 | 58.755 |
| 10:53 ET | 400 | 58.72 |
| 10:55 ET | 4253 | 58.6 |
| 10:57 ET | 1894 | 58.26 |
| 11:04 ET | 200 | 58.2 |
| 11:06 ET | 200 | 58.15 |
| 11:08 ET | 500 | 58.3 |
| 11:09 ET | 455 | 58.36 |
| 11:11 ET | 1862 | 58.52 |
| 11:18 ET | 1124 | 58.46 |
| 11:22 ET | 200 | 58.515 |
May 30, 2024
May 13, 2024
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares, from 4:05PM ET on Monday May 13, 2024 by Dow Jones
4:05PM ET on Monday May 13, 2024 by Dow JonesPress Release: RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares, from 4:05PM ET on Monday May 13, 2024 by Dow Jones
4:05PM ET on Monday May 13, 2024 by Dow Jones
May 8, 2024
*DJ RxSight, Inc. Announces Pricing of Public Offering of Common Stock, from 9:31PM ET on Wednesday May 08, 2024 by Dow Jones
9:31PM ET on Wednesday May 08, 2024 by Dow JonesRxSight, Inc. Announces Pricing of Public Offering of Common Stock, from 9:15PM ET on Wednesday May 08, 2024 by Dow Jones
9:15PM ET on Wednesday May 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rxsight Inc | 2.3B | -46.8x | --- |
STAAR Surgical Co | 2.0B | 138.1x | +31.52% |
Novocure Ltd | 2.4B | -13.3x | --- |
UFP Technologies Inc | 2.0B | 41.9x | +24.81% |
Warby Parker Inc | 2.1B | -37.7x | --- |
Myriad Genetics Inc | 2.1B | -8.1x | --- |
Company Information
RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
Contact Information
- Headquarters
- 100 COLUMBIA STREET, SUITE 120ALISO VIEJO, CA, United States 92656
- Phone
- 949-521-7822
- Fax
- 302-655-5049
Executives
- Independent Director
- Andy Corley
- President, Chief Executive Officer
- Ron Kurtz
- Chief Financial Officer
- Shelley Thunen
- Chief Operating Officer
- Ilya Goldshleger
- Chief Commercial Officer
- Eric Weinberg
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3B |
|---|---|
Revenue (TTM) | $101.1M |
Shares Outstanding | 38.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.25 |
Book Value | $4.44 |
P/E Ratio | -46.8x |
Price/Sales (TTM) | 22.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -48.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
